pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP
Mumbai, IN HQ
1996 Founded
2,240 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Neovascular Age-related Macular Degeneration
Approved · other · Neovacular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration for Neovacular Age-related Macular Degeneration is a Approved program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CRFB002A-MAX-IL-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Novartis Pharmaceuticals
- Phase
- Approved
- Modality
- other
- Indication
- Neovacular Age-related Macular Degeneration
- Status
- completed
- Trials
- 1